Drug Shortage Report for FLUOROURACIL INJECTION USP
Report ID | 1405 |
Drug Identification Number | 02182742 |
Brand name | FLUOROURACIL INJECTION USP |
Common or Proper name | Fluorouracil (5FU) |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FLUOROURACIL |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5 g/100 mL x 1 |
ATC code | L01BC |
ATC description | ANTIMETABOLITES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-03-02 |
Estimated end date | 2017-03-20 |
Actual end date | 2017-03-20 |
Shortage status | Resolved |
Updated date | 2017-03-21 |
Company comments | Released March 20, 2017 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v3 | 2017-03-15 | English | Compare |
v4 | 2017-03-15 | French | Compare |
v5 | 2017-03-21 | English | Compare |
v6 | 2017-03-21 | French | Compare |
Showing 1 to 6 of 6